Master Protocol for the Phase 1 Study of Cell Therapies in Multiple Myeloma
Summary
Third Opinion Trial Synopsis:
There is a plan or set of rules called the master protocol that is used in studies to test a kind of treatment called cell therapy. This type of treatment is being tested on people with a type of cancer called multiple myeloma that came back or didn't respond to other treatments. The first part of the study, called Phase 1, is being done to see if the cell therapy works and is safe. The people in the study will be watched for a long time to make sure the treatment doesn't cause any problems.
There is a plan or set of rules called the master protocol that is used in studies to test a kind of treatment called cell therapy. This type of treatment is being tested on people with a type of cancer called multiple myeloma that came back or didn't respond to other treatments. The first part of the study, called Phase 1, is being done to see if the cell therapy works and is safe. The people in the study will be watched for a long time to make sure the treatment doesn't cause any problems.
*Third Opinion AI Generated Synopsis
Trial Summary
Master protocol for cell therapy, Phase 1 proof-of-concept studies in relapsed and refractory multiple myeloma and includes long-term safety follow-up.
Master protocol for cell therapy, Phase 1 proof-of-concept studies in relapsed and refractory multiple myeloma and includes long-term safety follow-up.
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts: